I am a Consultant Haematologist and honorary clinical senior lecturer working in the CLL and lymphoma team at the University of Hospitals Southampton (UHS) and University of Southampton. I am a member of the UK chronic lymphocytic leukaemia forum and focus on the biology and treatment of chronic B cell lymphoproliferative disorders.

Dr Eyre is a consultant haematologist specialising in lymphoid malignancies in Oxford, UK.  He has completed an MD Doctorate Thesis in 2017. He is an investigator on several national lymphoid trials and has published over 175 peer-review articles on lymphoma and CLL.  He is the low grade lymphoma clinical trial research group chair in the UK. He is a core member several lymphoma studies groups. He is a member of the BSH guideline writing groups for various lymphoma subtypes. ​He is an Associate Editor at the British Journal of Haematology. He is the lead author for the new ESMO Lymphoma guidelines.

George Follows received his medical degree from Oxford University Medical School and completed his medical and haematology training in Newcastle and Edinburgh, and his PhD at Leeds University. After a period of post-doctoral research at Cambridge University he was appointed as the Clinical Lead for lymphoma, CLL and clinical trials at Cambridge University Hospitals. He is a former chair of the UK CLL Forum and CLL Guidelines Panel and currently chairs the UK Hodgkin Lymphoma Guidelines Panel. Professor Follows is the Visiting Professor of Haematology of the Anglia Ruskin Medical School and Associate Professor of Haematology at the University of Cambridge. He continues to work closely with partners in the pharmaceutical and biotechnology sectors and has authored/co-authored over 100 peer-reviewed papers in different areas of haematological biology and therapeutics in journals, including the New England Journal of Medicine, The Lancet, Journal of Clinical Oncology, Nature, Cell, and Nature Genetics.